Systematic review / meta-analysis / 2016
Soy isoflavone consumption was linked to a reduced risk of colorectal cancer, especially among Asian populations and in case-control studies.
A systematic review and meta-analysis of 17 epidemiologic studies (13 case-control and 4 prospective cohort studies) examined the association between soy isoflavone intake and colorectal cancer (CRC) risk. Soy isoflavone consumption was associated with reduced CRC risk (RR: 0.78, 95% CI: 0.72-0.85; I2 = 34.1%, P = 0.024). Subgroup analyses showed significant reductions for soy foods/products (RR: 0.79, 95% CI: 0.69-0.89), in Asian populations (RR: 0.79, 95% CI: 0.72-0.87), and in case-control studies (RR: 0.76, 95% CI: 0.68-0.84). The authors noted that other factors may affect this association due to the limited number of studies.
Shows an association, not proof of cause and effect.
- Study type
- Systematic review and meta-analysis of observational studies
- Who was studied
- Participants across 17 epidemiologic studies (13 case-control and 4 prospective cohort studies)
- What was measured
- Colorectal cancer (CRC) risk
THE PAPER
Soy isoflavone consumption and colorectal cancer risk: a systematic review and meta-analysis.
Yu Y, Jing X, Li H, Zhao X, Wang D. Sci Rep, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.